Human Papillomavirus (HPV) Vaccine Market Size
The Human Papillomavirus (HPV) Vaccine Market, valued at USD 4.12 billion in 2022, is projected to reach USD 10.64 billion by 2030. This substantial growth reflects a compound annual growth rate (CAGR) of 12.6% over the forecast period from 2023 to 2030. The increasing prevalence of HPV-related diseases, coupled with heightened awareness and...
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian